Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mutations may diminish
vaccine-induced protective immune responses, particularly as antibody titers wane over time. …

A candidate gene for the chromosome 1 Alzheimer's disease (AD) locus was identified (STM2).
The predicted amino acid sequence for STM2 is homologous to that of the recently …

Background The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged
in late 2019 and spread globally, prompting an international effort to accelerate development …

A vaccine for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is needed to
control the coronavirus disease 2019 (COVID-19) global pandemic. Structural studies have …

Cross-reactive neutralizing antibodies (NAbs) are found in the sera of many HIV-1–infected
individuals, but the virologic basis of their neutralization remains poorly understood. We …

Much evidence indicates that abnormal processing and extracellular deposition of amyloid-β
peptide (Aβ), a proteolytic derivative of the β-amyloid precursor protein (βAPP), is central to …

Persistence of Antibody after mRNA-1273 Vaccination A total of 33 participants who received
both doses of the Moderna mRNA-1273 vaccine against SARS-CoV-2 had blood drawn …

Background Testing of vaccine candidates to prevent infection with severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) in an older population is important, since increased …

… -mNG) assay on days 1, 29, 43, and 119 (Panel C); and the 80% inhibitory dilution (ID 80 )
titer on plaque-reduction neutralization testing (PRNT) assay on days 1, 43, and 119 (Panel D)…

Omicron Neutralization and mRNA-1273 Boosters Neutralization of the omicron variant was
assessed in serum samples obtained from persons who had received an mRNA-1273 …